These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6307433)

  • 1. Comparison of thrombin and ristocetin in the interaction between von Willebrand factor and platelets.
    Harrison RL; McKee PA
    Blood; 1983 Aug; 62(2):346-53. PubMed ID: 6307433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
    Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
    Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
    Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin.
    Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT
    Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor. A protein which binds at the cell surface interface between platelets.
    Senogles SE; Nelsestuen GL
    J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane.
    Howard MA; Perkin J; Salem HH; Firkin BG
    Br J Haematol; 1984 May; 57(1):25-35. PubMed ID: 6426499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
    De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.
    Phillips MD; Moake JL; Nolasco L; Turner N
    Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib.
    George JN; Torres MM
    Blood; 1988 May; 71(5):1253-9. PubMed ID: 3258766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets.
    Kupinski JM; Miller JL
    Thromb Res; 1986 Aug; 43(3):335-44. PubMed ID: 3016944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding.
    LaDuca FM; Bettigole RE; Bell WR; Robson EB
    Blood; 1986 Oct; 68(4):927-37. PubMed ID: 3489493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of calcium-dependent binding of endogenous factor VIII/von Willebrand factor to surface activated platelets.
    Furby FH; Berndt MC; Castaldi PA; Koutts J
    Thromb Res; 1984 Sep; 35(5):501-11. PubMed ID: 6435280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
    Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC
    Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury.
    Kornblith LZ; Robles AJ; Conroy AS; Hendrickson CM; Calfee CS; Fields AT; Callcut RA; Cohen MJ
    J Trauma Acute Care Surg; 2018 Nov; 85(5):873-880. PubMed ID: 29985231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.